Main Sequence Ventures has contributed to a $53.3m series B-plus for V2Food, having already backed the initial $55m series B round last October.

Osage University Partners has backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

China Merchants Capital has co-led a series B round sized at almost $99.2m that also attracted existing shareholder Legend Capital.

4490 Ventures-backed Rentable has received $22.5m in its series B round.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

China Life Private Equity Investment was among the investors in the Beijing Eswin subsidiary’s series B round, seven months after its reported series A.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

New and returning investors have chipped into the ETH Zurich plant-based meat spinout’s pre-series B round, five months after it completed a series A.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.